ALUULA Composites has reported, through the attached Shareholder letter, record preliminary unaudited fourth quarter 2025 ...
Tevogen Bio Holdings Inc. announced that CD8 Technology Services LLC has signed a letter of intent to design a facility that will support Tevogen’s cell therapy manufacturing efforts. CEO Ryan Saadi ...
Digital manufacturer Protolabs launched its rebranded Protolabs Network service, which is designed to leverage global manufacturing partners for expanded capabilities and pricing options. Formerly ...